Genotyping and haplotyping of CYP2C19 functional alleles on thin-film biosensor chipsNAKAMOTO, Kaori; KIDD, Judith R; JENISON, Robert D et al.Pharmacogenetics and genomics (Print). 2007, Vol 17, Num 2, pp 103-114, issn 1744-6872, 12 p.Article

Clopidogrel pathwaySANGKUHL, Katrin; KLEIN, Teri E; ALTMAN, Russ B et al.Pharmacogenetics and genomics (Print). 2010, Vol 20, Num 7, pp 463-465, issn 1744-6872, 3 p.Article

PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 19SCOTT, Stuart A; SANGKUHL, Katrin; SHULDINER, Alan R et al.Pharmacogenetics and genomics (Print). 2012, Vol 22, Num 2, pp 159-165, issn 1744-6872, 7 p.Article

Interaction magnitude, pharmacokinetics and pharmacodynamics of ticlopidine in relation to CYP2C19 genotypic statusIEIRI, Ichiro; KIMURA, Miyuki; IRIE, Shin et al.Pharmacogenetics and genomics (Print). 2005, Vol 15, Num 12, pp 851-859, issn 1744-6872, 9 p.Article

Contributions of CYP2D6, CYP2C9 and CYP2C19 to the biotransformation of E- and Z-doxepin in healthy volunteersKIRCHHEINERA, Julia; MEINEKE, Ingolf; MÜLLER, Gunnar et al.Pharmacogenetics (London). 2002, Vol 12, Num 7, pp 571-580, issn 0960-314X, 10 p.Article

Pharmacogenetic roles of CYP2C19 and CYP2B6 in the metabolism of R- and S-mephobarbital in humansKOBAYASHI, Kaoru; MORITA, Jun; CHIBA, Kan et al.Pharmacogenetics (London). 2004, Vol 14, Num 8, pp 549-556, issn 0960-314X, 8 p.Article

Allele and genotype frequency of CYP2C19 in Tamilian populationADITHAN, C; GERARD, N; VASU, S et al.British journal of clinical pharmacology. 2003, Vol 56, Num 3, pp 331-333, issn 0306-5251, 3 p.Article

Sequence diversity and functional characterization of the 5'-regulatory region of human CYP2C19AREFAYENE, Million; SKAARA, Todd C; FLOCKHART, David A et al.Pharmacogenetics (London). 2003, Vol 13, Num 4, pp 199-206, issn 0960-314X, 8 p.Article

Aminoglycoside-induced suppression of CYP2C19*3 premature stop codonFUCHSHUBER-MORAES, Mateus; SAMPAIO CARVALHO, Renato; RIMMBACH, Christian et al.Pharmacogenetics and genomics (Print). 2011, Vol 21, Num 11, pp 694-700, issn 1744-6872, 7 p.Article

Pharmacogenetic variation at CYP2C9, CYP2C19, and CYP2D6 at global and microgeographic scalesSISTONEN, Johanna; FUSELLI, Silvia; PALO, Jukka U et al.Pharmacogenetics and genomics (Print). 2009, Vol 19, Num 2, pp 170-179, issn 1744-6872, 10 p.Article

The influence of CYP2C19*2 and *17 on on-treatment platelet reactivity and bleeding events in patients undergoing elective coronary stentingHARMSZE, Ankie M; VAN WERKUM, Jochem W; DENEER, Vera H. M et al.Pharmacogenetics and genomics (Print). 2012, Vol 22, Num 3, pp 169-175, issn 1744-6872, 7 p.Article

Differential expression and function of CYP2C isoforms in human intestine and liverLÄPPLE, Florian; VON RICHTER, Oliver; FROMM, Martin F et al.Pharmacogenetics (London). 2003, Vol 13, Num 9, pp 565-575, issn 0960-314X, 11 p.Article

Utility and adoption of CYP2D6 and CYP2C19 genotyping and its translation into psychiatric clinical practiceJÜRGENS, G; JACOBSEN, C. B; RASMUSSEN, H. B et al.Acta psychiatrica scandinavica. 2012, Vol 125, Num 3, pp 228-237, issn 0001-690X, 10 p.Article

Association between blood carisoprodol:meprobamate concentration ratios and CYP2C19 genotype in carisoprodol-drugged drivers: decreased metabolic capacity in heterozygous CYP2C19*1/CYP2C19*2 subjects?BRAMNESS, Jørgen G; SKURTVEIT, Svetlana; FAUSKE, Lars et al.Pharmacogenetics (London). 2003, Vol 13, Num 7, pp 383-388, issn 0960-314X, 6 p.Article

CYP2C9, CYP2C19, ABCB1 (MDR1) genetic polymorphisms and phenytoin metabolism in a Black Beninese populationALLABI, Aurel C; GALA, Jean-Luc; HORSMANS, Yves et al.Pharmacogenetics and genomics (Print). 2005, Vol 15, Num 11, pp 779-786, issn 1744-6872, 8 p.Article

Integration of absorption, distribution, metabolism, and elimination genotyping data into a population pharmacokinetic analysis of nevirapineLEHR, Thorsten; JING YUAN; HALL, David et al.Pharmacogenetics and genomics (Print). 2011, Vol 21, Num 11, pp 721-730, issn 1744-6872, 10 p.Article

Pharmacogenetics and herb-drug interactions: experience with Ginkgo biloba and omeprazoleYIN, Ophelia Q. P; TOMLINSON, Brian; WAYE, Mary M. Y et al.Pharmacogenetics (London). 2004, Vol 14, Num 12, pp 841-850, issn 0960-314X, 10 p.Article

Concordance between proguanil phenotype and CYP2C19 genotype in ChineseHOSKINS, Janelle M; SHENFIELD, Gillian M; GROSS, Annette S et al.European journal of clinical pharmacology. 2003, Vol 59, Num 8-9, pp 611-614, issn 0031-6970, 4 p.Article

Low frequency of defective alleles of cytochrome P450 enzymes 2C19 and 2D6 in the Turkish populationAYNACIOGLU, A. S; SACHSE, C; BOZKURT, A et al.Clinical pharmacology and therapeutics. 1999, Vol 66, Num 2, pp 185-192, issn 0009-9236Article

Determinatin of CYP2C19 phenotype in black Americans with omeprazole : Correlation with genotypeMARINAC, J. S; BALIAN, J. D; FOXWORTH, J. W et al.Clinical pharmacology and therapeutics. 1996, Vol 60, Num 2, pp 138-144, issn 0009-9236Article

The hydroxylation of omeprazole correlates with S-mephenytoin metabolism : a population studyBALIAN, J. D; SUKHOVA, N; HARRIS, J. W et al.Clinical pharmacology and therapeutics. 1995, Vol 57, Num 6, pp 662-669, issn 0009-9236Article

Interferon-β treatment in patients with multiple sclerosis does not alter CYP2C19 or CYP2D6 activityHELLMAN, Karin; ROOS, Ewa; ÖSTERLUND, Anna et al.British journal of clinical pharmacology. 2003, Vol 56, Num 3, pp 337-340, issn 0306-5251, 4 p.Article

Association Between Inherited CYP2D6/2C19 Phenotypes and Anticholinergic Measures in Elderly Patients Using Anticholinergic DrugsKERSTEN, Hege; WYLLER, Torgeir B; MOLDEN, Espen et al.Therapeutic drug monitoring. 2014, Vol 36, Num 1, pp 125-130, issn 0163-4356, 6 p.Article

CYP2C19 genotype-phenotype discordance in patients with multiple myeloma leads to an acquired loss of drug-metabolising activityBURNS, K. E; GOLDTHORPE, M. A; PORTEUS, F et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 3, pp 651-655, issn 0344-5704, 5 p.Article

Evidence of polymorphic CYP2C19 involvement in the human metabolism of N-desmethylclobazamCONTIN, Manuela; SANGIORGI, Simonetta; RIVA, Roberto et al.Therapeutic drug monitoring. 2002, Vol 24, Num 6, pp 737-741, issn 0163-4356, 5 p.Article